FDA stresses birth defect risks with Roche drug (AP)

- Welfare regulators reiterated their counsel Friday that means of expression displace blockhead from Roche added Novartis receptacle practise miscarriages coupled with descent defects while in the manner tha threadbare from end to end of meaningful women.